Viewing Study NCT00782002


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-01-26 @ 9:32 AM
Study NCT ID: NCT00782002
Status: COMPLETED
Last Update Posted: 2010-09-30
First Post: 2008-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumors View
None VEGF-A View
None stromal cells View
None endothelial cells View
None malignant cells View